Association of Comorbid with Developmental Quotient in Down Syndrome Children

I Gusti Ayu  Trisna Windiani; Ni Made Dewi Aryati; I Gusti Agung Ngurah  Sugitha Adnyana; Ni Luh Sukma Pratiwi Murti; Soetjiningsih Soetjiningsih

doi:10.3889/oamjms.2021.6695

Authors

I Gusti Ayu Trisna Windiani Department of Child Health, Faculty of Medicine, Udayana University, Denpasar, Indonesia
Ni Made Dewi Aryati Department of Child Health, Faculty of Medicine, Udayana University, Denpasar, Indonesia
I Gusti Agung Ngurah Sugitha Adnyana Department of Child Health, Faculty of Medicine, Udayana University, Denpasar, Indonesia
Ni Luh Sukma Pratiwi Murti Department of Child Health, Faculty of Medicine, Udayana University, Denpasar, Indonesia
Soetjiningsih Soetjiningsih Department of Child Health, Faculty of Medicine, Udayana University, Denpasar, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2021.6695

Keywords:

Down syndrome, Comorbid, Cognitive, Caput Scale, Clinical adaptive test/Clinical linguistic and auditory milestone scale

Abstract

BACKGROUND: Down syndrome (DS) is the most common genetic disorder in children. Children with DS tend to have various comorbid due to developmental abnormalities of chromosome 21, such as congenital heart defects, hearing loss, otitis media, eye disorders, obstructive sleep apnea, thyroid hormone disorders, gastrointestinal atresia, hip joint dislocation, leukemia, and Hirschsprung’s disease. Moreover, they also show cognitive impairments in concentration, communication, memory, and the ability to carry out tasks. Caput Scale/Clinical Adaptive Test/Clinical Linguistic and Auditory Milestone Scale (CAT-CLAMS) is one of the developmental assessment instruments to screen for cognitive disorders.

AIM: Hereby, we aimed to find the association of comorbid with developmental quotient in DS children. Data were obtained from medical record with sample age 0–18 years and suffering from DS.

METHODS: This was observational analytic study with cross-sectional approach, conducted in DS children age 0–18 years who were treated in Sanglah Hospital in 2018. Characteristic data and comorbid were obtained from medical record, meanwhile, development status was assessed using Caput Scale/CAT-CLAMS. Chi-square was applied to determine the association between comorbidities and development quotient (DQ) in DS children.

RESULTS: A total of 32 children with DS were treated in Sanglah Hospital during 2018 with median age was 2 years old and dominated by female patient (71.9%). Several comorbidities were found such as endocrine disorders in 27 children (84.3%), congenital heart disease (CHD) in 16 children (50%), and other comorbid including microcephaly, congenital cataract, palatoschizis, gastrointestinal defects, and congenital talipes equinovarus in 13 children (40.4%). The most common endocrine disorders was congenital hypothyroidism (81.25%), while the most common CHD was patent ductus arteriosus (25%). Bivariate Chi-square analysis showed significant association between comorbid and DQ (PR = 1.4 [95% CI 0.95–1.97], p = 0.03).

CONCLUSION: We found an association between comorbidities and DQ in DS children.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Bull MJ, Committee on Genetics. Clinical report health supervision for children with down syndrome. Pediatrics. 2011;128(2):392-406. http://doi.org/10.1542/peds.2011-1605 PMid:21788214 DOI: https://doi.org/10.1542/peds.2011-1605

Committee on Genetics American Academy of Pediatrics. Health supervision for children with Down syndrome. Pediatrics. 2001;107(2):442-9. http://doi.org/10.1542/peds.107.2.442 PMid:11158488 DOI: https://doi.org/10.1542/peds.107.2.442

Lee B. Down Syndrome and other abnormalities of chromosome number. Dalam: Kliegman RM, Stanton BF, St Geme III JW, Schor NF, editor. Nelson Textbook of Pediatrics. 20th ed. Philadelphia, PA: Elsevier; 2016. p. 610-20.

Kawanto FH, Soedjatmiko. Monitoring of Growth and Development in Children with Down Syndrome. Sari Pediatri. 2007;9:185-90. DOI: https://doi.org/10.14238/sp9.3.2007.185-90

Malino Y, Soetjiningsih. Sindrom Down. In: Soetjiningsih, Gde Ranuh IG, editor. Tumbuh Kembang Anak. 2nd ed. Jakarta: Penerbit Buku Kedokteran EGC; 1995. p. 490-506.

Caban-Holt A, Head E, Schmitt F. Down syndrome. In: Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease. Ch. 15. Philadelphia: Elsevier; 2015. p. 163-70. DOI: https://doi.org/10.1016/B978-0-12-410529-4.00015-2

Myrelid A, Gustafsson, Ollars B, Anneren G. Growth charts for down’s syndrome from birth to 18 years of age. Arch Dis Child. 2002;87(2):97-103. http://doi.org/10.1136/adc.87.2.97 PMid:12138052 DOI: https://doi.org/10.1136/adc.87.2.97

Sularyo TS, Kadim M. Retardasi mental. Sari Pediatr. 2000;2:170-7. DOI: https://doi.org/10.14238/sp2.3.2000.170-7

Dhamayanti M, Herlina M. Skrining gangguan kognitif dan bahasa menggunakan caput scale. (Cognitive adaptive test/ clinical linguistic and auditory milestone scale-cat/clams). Sari Pediatr. 2009;11(3):189-98. DOI: https://doi.org/10.14238/sp11.3.2009.189-98

O’Keefe L. Caring for Children with Down syndrome. AAP News; 2002. p. 290.

Wajuihian SO. Down syndrome: An overview. Afr Vision Eye Health. 2016;75(1):a346. DOI: https://doi.org/10.4102/aveh.v75i1.346

Shalaby HM. A study of new potential risk factors for Down syndrome in Upper Egypt. Egypt J Med Hum Genet 2011;12(1):15-9. https://doi.org/10.1016/j.ejmhg.2011.02.009 DOI: https://doi.org/10.1016/j.ejmhg.2011.02.009

Podder G, Banerjee J, Madhusnata. Paternal age combined with maternal age influences the incidence of down syndrome. Int J Pharmacol Clin Res. 2014;6:186-8.

Sotonica M, Mackic-Djurovic M, Hasic S, Kiseljakovic E, Jadric R, Ibrulj S. Association of parental age and the type of down syndrome on the territory of Bosnia and Herzegovina. Med Arch 2016;70:88-91. DOI: https://doi.org/10.5455/medarh.2016.70.88-91

Alao MJ, Adjagba PM, Yekpe P. Congenital visceral malformations in children with Down syndrome followed in the pediatric unit of the CNHU, Cotonou, Benin. J Down Syndr Chr Abnorm. 2017;3:1-3. http://doi.org/10.4172/2472-1115.1000121 DOI: https://doi.org/10.4172/2472-1115.1000121

Stoll C, Dott B, Alembik Y, Roth MP. Associated congenital anomalies among case with Down syndrome. Eur J Med Genet. 2015;58(12):674-80. PMid:26578241 DOI: https://doi.org/10.1016/j.ejmg.2015.11.003

Poaty H, Niama AC, Voumbo MY. Prevalence and pattern of associated anomalies in preliminary working among Congolese children with Down syndrome: Analysis of 83 patients and African review. J Genet Disord. 2018;2:1-5.

Unachak K, Tanpaiboon P, Pongprot Y, Sittivangkul R, Silvilairat S, Dejkhamron P, Sudasna J. Thyroid functions in children with Down’s syndrome. J Med Assoc Thai. 2008;91(1):56-61. PMid:18386545

King K, O’Gorman CS, Gallagher S. An audit of the management of thyroid disease in children with Down syndrome. Ir Med J. 2014;107(4):118-9. PMid:24834588

Jalili Z, Jalili S. Congenital heart disease in children with Down syndrome in Kermanshah, West of Iran during 2002-2016. Int J Pediatr. 2017;5:6095-102.

Elmagrpy Z, Rayani A, Shah A, Habas E, Aburawi E. Down syndrome and congenital heart disease: Why the regional differences as observed in the Libyan experience? CVJ Afr. 2011;22:306-9. DOI: https://doi.org/10.5830/CVJA-2010-072

Benhaourech S, Drighil A, Hammiri AE. Congenital heart disease and Down syndrome: Various aspect of confirmed association. CVJ Afr. 2016;27(5):287-90. http://doi.org/10.5830/CVJA-2016-019 PMid:27805241 DOI: https://doi.org/10.5830/CVJA-2016-019

Forsey JT, Elmasry OA, Martin RP. Patent arterial duct. Orphanet J Rare Dis. 2009;4(1):17. http://doi.org/10.1186/1750-1172-4-17 PMid:19591690 DOI: https://doi.org/10.1186/1750-1172-4-17

Abbag FI. Congenital heart diseases and other major anomalies in patients with Down syndrome. Saudi Med J. 2006;27(2):219-22. PMid:16501680

Vadakedom SS, Krishnan DK, Mammen DS, Bindhu KP, Antony JM. Medical problems in children with Down syndrome. Int J Adv Med. 2018;5:1290-94. DOI: https://doi.org/10.18203/2349-3933.ijam20183910

Aoki S, Yamauchi Y, Hashimoto K. Developmental trend of children with Down’s syndrome -How do sex and neonatal conditions influence their developmental patterns? Brain Dev Jpn. 2018;40:181-7. DOI: https://doi.org/10.1016/j.braindev.2017.10.001

Kim HI, Kim SW, Kim J, Jeon HR, Jung DW. Motor and cognitive developmental profile in children with Down syndrome. Ann Rehabil Med. 2017;41(1):97-103. http://doi.org/10.5535/ arm.2017.41.1.97 PMid:28289641 DOI: https://doi.org/10.5535/arm.2017.41.1.97

Wasant P, Boonyawat B, Tritilanunt S, Vatanavicharn N, Sathienkijakanchai A, Ratanarak P, et al. Factors influencing development of Down syndrome children in the first three years of life: Siriraj experience. J Med Assoc Thai. 2008;91(7):1030-7. PMid:18839841